Comments
Pharma major Dr Reddy’s Laboratories Ltd has launched Clofarabine injection, a therapeutic and generic equivalent of Clolar injection of Genzyme Corporation, in the US market.
The Clolar brand and generic had the US sales of approximately $53 million for the most recent 12 months ended September 2017 as per IMS Health, the Hyderabad-based company said in a release issued here on Tuesday. The drug is used in treating a particular type of cancer, among other prescribed use.
Comments
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.